- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
NEW YORK ( TheStreet) -- NxStage Medical Incorporated (Nasdaq: NXTM) hit a new 52-week low Thursday as it is currently trading at $16.24, below its previous 52-week low of $16.29 with 93,900 shares traded as of 10:20 a.m. ET. Average volume has been 437,400 shares over the past 30 days. NxStage Medical has a market cap of $993.1 million and is part of the health care sector and health services industry. Shares are down 5.8% year to date as of the close of trading on Wednesday. NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures.